Last C$0.03 CAD
Change Today 0.00 / 0.00%
Volume 0.0
KNE On Other Exchanges
Symbol
Exchange
Venture
OTC US
Berlin
As of 3:59 PM 10/30/14 All times are local (Market data is delayed by at least 15 minutes).

kane biotech inc (KNE) Snapshot

Open
C$0.04
Previous Close
C$0.03
Day High
C$0.04
Day Low
C$0.03
52 Week High
02/5/14 - C$0.13
52 Week Low
10/30/14 - C$0.03
Market Cap
2.5M
Average Volume 10 Days
221.6K
EPS TTM
C$-0.01
Shares Outstanding
82.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for KANE BIOTECH INC (KNE)

Related News

No related news articles were found.

kane biotech inc (KNE) Related Businessweek News

No Related Businessweek News Found

kane biotech inc (KNE) Details

Kane Biotech Inc., a biotechnology company, is engaged in the development and commercialization of products to prevent and remove biofilms. Its products include DispersinB, an antibiofilm enzyme for the wound care market; Aledex for the medical device coating market; KBI antibacterial disinfectant; and StrixNB for the oral care market. The company was founded in 2001 and is based in Winnipeg, Canada.

Founded in 2001

kane biotech inc (KNE) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: C$195.0K
Chief Financial Officer
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

kane biotech inc (KNE) Key Developments

Kane Biotech Appoints Mark Nawacki to the Board of Directors

Kane Biotech Inc. announced the appointment of Mark Nawacki to its board of directors. Mark will be replacing Richard Cherney who is retiring from the board. Mr. Nawacki served as Executive Vice President, Business and Corporate Development of Paladin until September 2014. Mark joined Paladin in 2003 and was responsible for all business, corporate and product development activities.

Kane Biotech Inc. Auditor Raises 'Going Concern' Doubt

Kane Biotech Inc. filed its Annual on Apr 03, 2014 for the period ending Dec 31, 2013. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Kane Biotech Inc., Annual General Meeting, Jun 04, 2014

Kane Biotech Inc., Annual General Meeting, Jun 04, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KNE:CN C$0.03 CAD 0.00

KNE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KNE.
View Industry Companies
 

Industry Analysis

KNE

Industry Average

Valuation KNE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 17.0x
Price/Book 3.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 11.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KANE BIOTECH INC, please visit www.kanebiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.